Abstract
The Rapid Assessment for Developmental Disabilities (RADD) was developed to address the challenges of measuring cognition in individuals with intellectual disabilities (ID). As opposed to individuals with ID, commonly used intelligence tests such as the Wechsler Intelligence Scale for Children (WISC) [1], the Wechsler Adult Intelligence Scales (WAIS) [2], and the Stanford-Binet (SB) [3] were designed for use with the general population [4]. By design on these measures approximately 95% of the population have IQ scores that fall within two standard deviations (SD) from the mean (scores between 70 and 130; Fig. 12.1). Individuals with ID typically have IQ scores more than two SDs from the mean and they represent less than 2.5% of the total population, forming a statistically rare group. Commonly used intelligence tests were not designed to differentiate between the varying levels of ability among individuals at this lowest end of the intelligence spectrum. The RADD was developed to fill the need for measuring the cognitive abilities of individuals with IQ scores more than two standard deviations below the mean (scores below 70).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wechsler D. Wechsler intelligence scale for children. 3rd ed. San Antonio: Harcourt Brace and Company; 1991.
Wechsler D. Wechsler adult intelligence scale. 3rd ed. San Antonio: Harcourt Brace and Company; 1997.
Thorndike RL, Hagen EP, Sattler JM. Stanford binet intelligence scale. 4th ed. Chicago: Riverside Publishing; 1987.
Rabin LA, Barr WB, Burton LA. Assessment practices of clinical neuropsychologists in the United States and Canada: a survey of INS, NAN, and APA division 40 members. Arch Clin Neuropsychol. 2005;20:33–65.
Borthwick-Duffy SA. Epidemiology and prevalence of psychopathology in people with mental retardation. J Consult Clin Psychol. 1994;62:17–27.
Sattler JM. Assessment of children, revised and updated. 3rd ed. San Diego: Jerome M. Sattler Publishing; 1992.
Sattler JM. Assessment of children: cognitive applications. 4th ed. San Diego: Jerome M. Sattler Publisher; 2001.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 2004.
Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press; 1995.
Slosson RL. Technical manual. Slosson intelligence test. New York: Slosson Educational Publications; 1982.
Kaufman AS, Kaufman NL. Manual for the Kaufman brief intelligence test. Circle Pines: American Guidance Service; 1990.
Folstein MF, Folstein SE, McHugh PR. Mini-mental state. J Psych Res. 1975;12:189–98.
Harrell LE, Marson D, Chatterjee A, et al. The severe mini-mental state examination for the bedside assessment of severely impaired patients with Alzheimer’s disease. Alzheimer Dis Assoc Disord. 2000;14:168–75.
Gardner MF. Expressive one-word picture vocabulary test—revised manual. Novato: Academic Therapy Publications; 1990.
Dunn LM, Dunn LM. Peabody picture vocabulary test—revised manual for forms L and M. Circle Pines: American Guidance Service; 1981.
Stutsman R. Guide for administering the Merrill-Palmer scale of mental tests. Chicago: Stoelting Company; 1948.
Parks S. Curriculum-based assessment birth to three years: adapted from the Hawaii early learning profile. Palo Alto: VORT Corporation; 1996.
Walsh DM, Finwall J, McGregor M, et al. Rapid assessment of severe cognitive impairment in individuals with developmental disabilities. J Intellect Disabil Res. 2007;51:91–100.
Walsh DM, Doran E, Silverman W, et al. Rapid assessment of cognitive function in Down syndrome across intellectual level and dementia status. J Intellect Disabil Res. 2015;59:1071–9.
World Health Organisation. The ICD-10 classification of mental and behavioural disorders. Geneva: World Health Organisation; 1992.
Dalton A. Dyspraxia scale for adults with Down syndrome. Staten Island: Institute for Basic Research in Developmental Disabilities; 1997.
Panisset M, Roudier M, Saxton J, et al. Severe impairment battery: a neuropsychological test for severely demented patients. Arch Neurol. 1994;51:41–5.
Evenhuis HM. Further evaluation of the dementia questionnaire for persons with mental retardation (DMR). J Intellect Disabil Res. 1996;40:369–73.
Evenhuis HM. Evaluation of a screening instrument for dementia in ageing mentally retarded persons. J Intellect Disabil Res. 1992;36:337–47.
Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561–77.
Bucks RS, Ashworth DL, Wilcock GK, et al. Assessment of activities of daily living in dementia: development of the Bristol activities of daily living scale. Age Ageing. 1996;25:113–20.
Krinsky-McHale SJ, Silverman W. Dementia and mild cognitive impairment in adults with intellectual disability: issues of diagnosis. Dev Disabl Res Rev. 2013;18:31–42.
Elliott-King J, Shaw S, Bandelow S, et al. A critical literature review of the effectiveness of various instruments in the diagnosis of dementia in adults with intellectual disabilities. Alzheimers Dement (Amst). 2016;4:126–48.
Janicki MP, Keller SM. Why do we need national guidelines for adults with intellectual disability and dementia? Alzheimers Dement (Amst). 2015;1:325–7.
Sabbagh M, Edgin J. Clinical assessment of cognitive decline in adults with Down syndrome. Curr Alzheimer Res. 2016;13:30–4.
Burt DB, Primeaux-Hart S, Loveland KA, et al. Comparing dementia diagnostic methods used with people with intellectual disabilities. J Policy Pract Intellect Disabil. 2015;2:94–115.
Burt DB, Primeaux-Hart S, Loveland KA, et al. Tests and medical conditions associated with dementia diagnosis. J Policy Pract Intellect Disabil. 2005;2:47–56.
Silverman W, Schupf N, Zigman W, et al. Dementia in adults with mental retardation: assessment at a single point in time. Am J Ment Retard. 2004;109:111–25.
Burt DB. Issues in dementia assessment methods. In: Prasher VP, editor. Neuropsychological assessment of dementia in Down syndrome and intellectual disabilities. London: Springer; 2009. p. 19–38.
Kay DW, Tyrer SP, Margallo-Lana ML, et al. Preliminary evaluation of a scale to assess cognitive function in adults with Down’s syndrome: the Prudhoe cognitive function test. J Intellect Disabil Res. 2003;47:155–68.
Deb S, Braganza J. Comparison of rating scales for the diagnosis of dementia in adults with Down’s syndrome. J Intellect Disabil Res. 1999;43:400–7.
Hon J, Huppert FA, Holland AJ, et al. Neuropsychological assessment of older adults with Down's syndrome: an epidemiological study using the Cambridge cognitive examination (CAMCOG). Br J Clin Psychol. 1999;38:155–65.
Kirk LJ, Hick R, Laraway A. Assessing dementia in people with learning disabilities: the relationship between two screening measures. J Intellect Disabil Res. 2006;10:357–64.
Solomon PR, Hirschoff A, Kelly B, et al. A 7 minute neurocognitive screening battery highly sensitive to Alzheimer’s disease. Arch Neurol. 1988;55:349–55.
Edgin JO, Mason GM, Allman MJ, et al. Development and validation of the Arizona cognitive test battery for Down syndrome. J Neurodev Disord. 2010;2:149–64.
Breslin J, Spanò G, Bootzin R, et al. Obstructive sleep apnea syndrome and cognition in Down syndrome. Dev Med Child Neurol. 2014;56:657–64.
Visootsak J, Huddleston L, Buterbaugh A, et al. Influence of CHDs on psycho-social and neurodevelopmental outcomes in children with Down syndrome. Cardiol Young. 2016;26:250–6.
Hithersay R, Hamburg S, Knight B, et al. Cognitive decline and dementia in Down syndrome. Curr Opin Psychiatry. 2016;30:102–7.
Esbensen AJ, Johnson EB, Amaral JL, et al. Differentiating aging among adults with Down syndrome and comorbid dementia or psychopathology. Am J Intellect Dev Disabil. 2016;121:13–24.
Wesnes KA, Edgar CJ. The role of human cognitive neuroscience in drug discovery for the dementias. Curr Opin Pharmacol. 2014;14:62–73.
Kozauer N, Katz R. Regulatory innovation and drug development for early-stage Alzheimer's disease. N Engl J Med. 2013;368:1169–71.
Ferris SH, Lucca U, Mohs R, et al. Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International working group on harmonization of dementia drug guidelines. Alzheimer Dis Assoc Disord. 1997;11(Suppl 3):34–8.
McCabe LL, McCabe ERB. Personalized medicine for individuals with Down syndrome. Mol Genet Metab. 2011;104:7–9.
Acknowledgements
The US National Institutes of Health supported this study through the following grants: P50AG16573; R01AG 21912; R01HD065160; U01AG051412. The National Center for Research Resources and the National Center for Advancing Translational Sciences supported this study through Grant UL1 TR000153.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Hom, C.L., Walsh, D.M., Doran, E., Lott, I.T. (2018). The Rapid Assessment for Developmental Disabilities. In: Prasher, V. (eds) Neuropsychological Assessments of Dementia in Down Syndrome and Intellectual Disabilities. Springer, Cham. https://doi.org/10.1007/978-3-319-61720-6_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-61720-6_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61719-0
Online ISBN: 978-3-319-61720-6
eBook Packages: MedicineMedicine (R0)